ATHENA Trial: Post Adjuvant Chemo in Ovarian Cancer | Premal Thaker, MD, MS | ASCO22 GYN Updates

The TRIAL OF ATHENAПодробнее

Premal Thaker, MD, MSПодробнее

GEJ Adenocarcinoma Treatment Based on ESOPEC Study | Daniel Catenacci, MD | ASCO22 GI Cancer UpdatesПодробнее

Management of Ovarian Cancer: Diagnosis to Survivorship and OvarcomingПодробнее

Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian CancerПодробнее

Gynecologic oncology research at ASCO 2017: Endometrial cancer trialsПодробнее

Doc Talk: Premal Thaker, MD, MS on Low-Grade Serous Ovarian Cancer Research | Let’s Talk About LGSOCПодробнее

Gynecologic Oncology at ASCO 2022: ATHENA–MONO Trial (Rucaparib Monotherapy) for Ovarian CancerПодробнее

Ovarian cancer at ESMO 2024: PRIMA and ATHENAПодробнее

Role of Immunotherapy In Recurrence Management Of Ovarian Cancer.Подробнее

All About Ovarian Cancer | Jacob Tangir, MD, The Center for Gynecologic OncologyПодробнее

An Overview of the MA17R Trial in Breast CancerПодробнее

Case 1: Use of Maintenance Therapy in Ovarian CancerПодробнее

Adjuvo: adjuvant mitotane in patients with AC and low-intermediate risk of recurrence post-surgeryПодробнее

Metastatic Ovarian Cancer TreatmentПодробнее

Dr. Konstantinopoulos on the Phase III Results of the JAVELIN 200 Trial in Ovarian CancerПодробнее

Toxicities Associated With Rucaparib for the Treatment of Ovarian CancerПодробнее

When Should You See a Gynecologic Oncologist? — AMITA HealthПодробнее